Unknown

Dataset Information

0

KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance.


ABSTRACT: Members of the KDM5 histone H3 lysine 4 demethylase family are associated with therapeutic resistance, including endocrine resistance in breast cancer, but the underlying mechanism is poorly defined. Here we show that genetic deletion of KDM5A/B or inhibition of KDM5 activity increases sensitivity to anti-estrogens by modulating estrogen receptor (ER) signaling and by decreasing cellular transcriptomic heterogeneity. Higher KDM5B expression levels are associated with higher transcriptomic heterogeneity and poor prognosis in ER+ breast tumors. Single-cell RNA sequencing, cellular barcoding, and mathematical modeling demonstrate that endocrine resistance is due to selection for pre-existing genetically distinct cells, while KDM5 inhibitor resistance is acquired. Our findings highlight the importance of cellular phenotypic heterogeneity in therapeutic resistance and identify KDM5A/B as key regulators of this process.

SUBMITTER: Hinohara K 

PROVIDER: S-EPMC6310147 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4975413 | biostudies-literature
| S-EPMC6028249 | biostudies-literature
| S-EPMC5854480 | biostudies-literature
| S-EPMC6749836 | biostudies-literature
| S-EPMC9938590 | biostudies-literature
| S-EPMC7058283 | biostudies-literature
| S-EPMC4684901 | biostudies-literature
| S-EPMC7945993 | biostudies-literature
2018-10-03 | GSE104988 | GEO
2018-10-03 | GSE104987 | GEO